Identification of a common low density lipoprotein receptor mutation (R329X) in the south of England: Complete linkage disequilibrium with an allele of microsatellite D19S394

被引:30
作者
Day, INM [1 ]
Haddad, L [1 ]
ODell, SD [1 ]
Day, LB [1 ]
Whittall, RA [1 ]
Humphries, SE [1 ]
机构
[1] UNIV SOUTHAMPTON, SOUTHAMPTON GEN HOSP, SOUTHAMPTON SO9 4XY, HANTS, ENGLAND
关键词
LDL receptor; familial hypercholesterolaemia;
D O I
10.1136/jmg.34.2.111
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Familial hypercholesterolaemia is commonly caused by mutations in the low density lipoprotein receptor (LDLR) gene and more than 300 different mutations have been described worldwide. Some mutations occur at relatively higher frequency in certain populations, reflecting both chance and demography, most evident in founder populations. As part of a study of kindreds of 78 probands from Southampton and south west Hampshire, we identified the same mutation (R329X) in 9/78 (11.5%) probands. In all (100%) of these probands, length allele 259nt of the 17 allele microsatellite D19S394, sited approximately 250 kilobases telomeric and 5' to the LDLR gene, was observed, although in the general population this allele has a prevalence of only 16.1%. A simple diagnostic assay for R329X was constructed in conjunction with more detailed family studies. Both the R329X and linked D19S394 allele also cosegregated with the FH phenotype within each kindred. Although R329X involves a CpG site, it is highly likely that the families are identical by descent for R329X, we surmise with a common ancestor within 500 to 1000 years, although the mutation is not restricted to this geographical area. This relationship illustrates that the linkage disequilibrium of gene LDLR with marker D19S394 will enable rapid recognition using D19S394 genotype of possible common FH mutation(s) within a cohort of FH patients from a particular locality or ethnic group.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 22 条
  • [1] AN INTEGRATED METRIC PHYSICAL MAP OF HUMAN-CHROMOSOME-19
    ASHWORTH, LK
    BATZER, MA
    BRANDRIFF, B
    BRANSCOMB, E
    DEJONG, P
    GARCIA, E
    GARNES, JA
    GORDON, LA
    LAMERDIN, JE
    LENNON, G
    MOHRENWEISER, H
    OLSEN, AS
    SLEZAK, T
    CARRANO, AV
    [J]. NATURE GENETICS, 1995, 11 (04) : 422 - 427
  • [2] BOLLA MK, 1995, CLIN CHEM, V41, P1599
  • [3] COMBINATION TREATMENT WITH CHOLESTYRAMINE AND BEZAFIBRATE FOR HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    CURTIS, LD
    DICKSON, AC
    LING, KLE
    BETTERIDGE, J
    [J]. BRITISH MEDICAL JOURNAL, 1988, 297 (6642) : 173 - 175
  • [4] ELECTROPHORESIS FOR GENOTYPING - MICROTITER ARRAY DIAGONAL GEL-ELECTROPHORESIS ON HORIZONTAL POLYACRYLAMIDE GELS, HYDROLINK, OR AGAROSE
    DAY, INM
    HUMPHRIES, SE
    [J]. ANALYTICAL BIOCHEMISTRY, 1994, 222 (02) : 389 - 395
  • [5] DAY INM, IN PRESS HUM MUTAT
  • [6] Goldstein JL, 1989, METABOLIC BASIS INHE, P1215
  • [7] IDENTIFICATION OF RECURRENT AND NOVEL MUTATIONS IN EXON 4 OF THE LDL RECEPTOR GENE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE UNITED-KINGDOM
    GUDNASON, V
    KINGUNDERWOOD, L
    SEED, M
    SUN, XM
    SOUTAR, AK
    HUMPHRIES, SE
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (01): : 56 - 63
  • [8] Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602
  • [9] IDENTIFICATION OF DELETIONS IN THE HUMAN LOW-DENSITY-LIPOPROTEIN RECEPTOR GENE
    HORSTHEMKE, B
    DUNNING, A
    HUMPHRIES, S
    [J]. JOURNAL OF MEDICAL GENETICS, 1987, 24 (03) : 144 - 147
  • [10] REGRESSION OF CORONARY ATHEROSCLEROSIS DURING TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA WITH COMBINED DRUG REGIMENS
    KANE, JP
    MALLOY, MJ
    PORTS, TA
    PHILLIPS, NR
    DIEHL, JC
    HAVEL, RJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (23): : 3007 - 3012